1942 related articles for article (PubMed ID: 17720468)
21. Epigenetic interplay between histone modifications and DNA methylation in gene silencing.
Vaissière T; Sawan C; Herceg Z
Mutat Res; 2008; 659(1-2):40-8. PubMed ID: 18407786
[TBL] [Abstract][Full Text] [Related]
22. Histone acetylation in gene regulation.
Verdone L; Agricola E; Caserta M; Di Mauro E
Brief Funct Genomic Proteomic; 2006 Sep; 5(3):209-21. PubMed ID: 16877467
[TBL] [Abstract][Full Text] [Related]
23. The histone deacetylase inhibitor trichostatin A downregulates human MDR1 (ABCB1) gene expression by a transcription-dependent mechanism in a drug-resistant small cell lung carcinoma cell line model.
El-Khoury V; Breuzard G; Fourré N; Dufer J
Br J Cancer; 2007 Aug; 97(4):562-73. PubMed ID: 17667922
[TBL] [Abstract][Full Text] [Related]
24. Prospects: histone deacetylase inhibitors.
Dokmanovic M; Marks PA
J Cell Biochem; 2005 Oct; 96(2):293-304. PubMed ID: 16088937
[TBL] [Abstract][Full Text] [Related]
25. Histone deacetylases regulate multicellular development in the social amoeba Dictyostelium discoideum.
Sawarkar R; Visweswariah SS; Nellen W; Nanjundiah V
J Mol Biol; 2009 Sep; 391(5):833-48. PubMed ID: 19576222
[TBL] [Abstract][Full Text] [Related]
26. Epigenetic control of ovarian function: the emerging role of histone modifications.
LaVoie HA
Mol Cell Endocrinol; 2005 Nov; 243(1-2):12-8. PubMed ID: 16219412
[TBL] [Abstract][Full Text] [Related]
27. Histone deacetylase 3 represses HTLV-1 tax transcription.
Villanueva R; Iglesias AH; Camelo S; Sanin LC; Gray SG; Dangond F
Oncol Rep; 2006 Sep; 16(3):581-5. PubMed ID: 16865259
[TBL] [Abstract][Full Text] [Related]
28. Potent stimulation of gene expression by histone deacetylase inhibitors on transiently transfected DNA.
Nan X; Hyndman L; Agbi N; Porteous DJ; Boyd AC
Biochem Biophys Res Commun; 2004 Nov; 324(1):348-54. PubMed ID: 15465025
[TBL] [Abstract][Full Text] [Related]
29. Acetylation of proteins as novel target for antitumor therapy: review article.
Di Gennaro E; Bruzzese F; Caraglia M; Abruzzese A; Budillon A
Amino Acids; 2004 Jul; 26(4):435-41. PubMed ID: 15290351
[TBL] [Abstract][Full Text] [Related]
30. Resetting the epigenetic histone code in the MRL-lpr/lpr mouse model of lupus by histone deacetylase inhibition.
Garcia BA; Busby SA; Shabanowitz J; Hunt DF; Mishra N
J Proteome Res; 2005; 4(6):2032-42. PubMed ID: 16335948
[TBL] [Abstract][Full Text] [Related]
31. Histone deacetylase inhibitors induce apoptosis, histone hyperacetylation and up-regulation of gene transcription in Schistosoma mansoni.
Dubois F; Caby S; Oger F; Cosseau C; Capron M; Grunau C; Dissous C; Pierce RJ
Mol Biochem Parasitol; 2009 Nov; 168(1):7-15. PubMed ID: 19538992
[TBL] [Abstract][Full Text] [Related]
32. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
[TBL] [Abstract][Full Text] [Related]
33. Inflammatory signalling as mediator of epigenetic modulation in tissue-specific chronic inflammation.
Bäckdahl L; Bushell A; Beck S
Int J Biochem Cell Biol; 2009 Jan; 41(1):176-84. PubMed ID: 18793748
[TBL] [Abstract][Full Text] [Related]
34. Corticosteroids: the drugs to beat.
Barnes PJ
Eur J Pharmacol; 2006 Mar; 533(1-3):2-14. PubMed ID: 16436275
[TBL] [Abstract][Full Text] [Related]
35. Histone deacetylation in epigenetics: an attractive target for anticancer therapy.
Mai A; Massa S; Rotili D; Cerbara I; Valente S; Pezzi R; Simeoni S; Ragno R
Med Res Rev; 2005 May; 25(3):261-309. PubMed ID: 15717297
[TBL] [Abstract][Full Text] [Related]
36. Histone deacetylase-2 and airway disease.
Barnes PJ
Ther Adv Respir Dis; 2009 Oct; 3(5):235-43. PubMed ID: 19812111
[TBL] [Abstract][Full Text] [Related]
37. Pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancer.
Zhong S; Fields CR; Su N; Pan YX; Robertson KD
Oncogene; 2007 Apr; 26(18):2621-34. PubMed ID: 17043644
[TBL] [Abstract][Full Text] [Related]
38. Histone deacetylase inhibitors--a new tool to treat cancer.
Somech R; Izraeli S; J Simon A
Cancer Treat Rev; 2004 Aug; 30(5):461-72. PubMed ID: 15245778
[TBL] [Abstract][Full Text] [Related]
39. Differential expression of human histone deacetylase mRNAs in response to immune cell apoptosis induction by trichostatin A and butyrate.
Dangond F; Gullans SR
Biochem Biophys Res Commun; 1998 Jun; 247(3):833-7. PubMed ID: 9647779
[TBL] [Abstract][Full Text] [Related]
40. Epigenetic regulation of maspin expression in the human placenta.
Dokras A; Coffin J; Field L; Frakes A; Lee H; Madan A; Nelson T; Ryu GY; Yoon JG; Madan A
Mol Hum Reprod; 2006 Oct; 12(10):611-7. PubMed ID: 16936308
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
